Survey of ophthalmology
Glucagon-like peptide-1 receptor agonists: What ophthalmologists need to know.
Suraj Bala, Kevin C Allan, Nicole L Decker, Nadia J Abbass, Julia H Joo, Alison Zhao, Katherine E Talcott, Aleksandra V Rachitskaya
Published: 202510.1016/j.survophthal.2025.12.007
Abstract
Initially designed for the treatment of type-2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1RA) are multifaceted agents with promising neuroprotective and anti-inflammatory properties. The majority of the research exploring the relations…
Preview only. Read the full abstract at the source